The global Antibody Drugs market is projected to grow from US$ 141260 million in 2024 to US$ 239390 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period.

Antibody Drugs Market

This report mainly focuses on antibody drugs market. Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Antibody Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Antibody Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Antibody Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Antibody Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Antibody Drugs sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Antibody Drugs Market Report

Report Metric	Details
Report Name	Antibody Drugs Market
Accounted market size in 2024	US$ 141260 million
Forecasted market size in 2030	US$ 239390 million
CAGR	9.2
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Monoclonal Antibodies Antibody-Drug Conjugates Polyclonal Antibodies
Segment by Application	Central Nervous System (CNS) Disorders Cancers Autoimmune Disorders Cardiovascular Diseases
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson & Johnson, AbbVie, Eli Lilly, Pfizer, Bayer, GlaxoSmithKline, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Antibody Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Antibody Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Antibody Drugs Market growing?

Ans: The Antibody Drugs Market witnessing a CAGR of 9.2 during the forecast period 2025-2030.

What is the Antibody Drugs Market size in 2030?

Ans: The Antibody Drugs Market size in 2030 will be US$ 239390 million.

Who are the main players in the Antibody Drugs Market report?

Ans: The main players in the Antibody Drugs Market are Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson & Johnson, AbbVie, Eli Lilly, Pfizer, Bayer, GlaxoSmithKline, Sanofi

What are the Application segmentation covered in the Antibody Drugs Market report?

Ans: The Applications covered in the Antibody Drugs Market report are Central Nervous System (CNS) Disorders, Cancers, Autoimmune Disorders, Cardiovascular Diseases

What are the Type segmentation covered in the Antibody Drugs Market report?

Ans: The Types covered in the Antibody Drugs Market report are Monoclonal Antibodies, Antibody-Drug Conjugates, Polyclonal Antibodies

1 Study Coverage

1.1 Antibody Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Antibody Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Monoclonal Antibodies

1.2.3 Antibody-Drug Conjugates

1.2.4 Polyclonal Antibodies

1.3 Market by Application

1.3.1 Global Antibody Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Central Nervous System (CNS) Disorders

1.3.3 Cancers

1.3.4 Autoimmune Disorders

1.3.5 Cardiovascular Diseases

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Antibody Drugs Sales Estimates and Forecasts 2019-2030

2.2 Global Antibody Drugs Revenue by Region

2.2.1 Global Antibody Drugs Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Antibody Drugs Revenue by Region (2019-2024)

2.2.3 Global Antibody Drugs Revenue by Region (2025-2030)

2.2.4 Global Antibody Drugs Revenue Market Share by Region (2019-2030)

2.3 Global Antibody Drugs Sales Estimates and Forecasts 2019-2030

2.4 Global Antibody Drugs Sales by Region

2.4.1 Global Antibody Drugs Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Antibody Drugs Sales by Region (2019-2024)

2.4.3 Global Antibody Drugs Sales by Region (2025-2030)

2.4.4 Global Antibody Drugs Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Antibody Drugs Sales by Manufacturers

3.1.1 Global Antibody Drugs Sales by Manufacturers (2019-2024)

3.1.2 Global Antibody Drugs Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antibody Drugs in 2023

3.2 Global Antibody Drugs Revenue by Manufacturers

3.2.1 Global Antibody Drugs Revenue by Manufacturers (2019-2024)

3.2.2 Global Antibody Drugs Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Antibody Drugs Revenue in 2023

3.3 Global Key Players of Antibody Drugs, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Antibody Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Antibody Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Antibody Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Antibody Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Antibody Drugs Sales by Type

4.1.1 Global Antibody Drugs Historical Sales by Type (2019-2024)

4.1.2 Global Antibody Drugs Forecasted Sales by Type (2025-2030)

4.1.3 Global Antibody Drugs Sales Market Share by Type (2019-2030)

4.2 Global Antibody Drugs Revenue by Type

4.2.1 Global Antibody Drugs Historical Revenue by Type (2019-2024)

4.2.2 Global Antibody Drugs Forecasted Revenue by Type (2025-2030)

4.2.3 Global Antibody Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Antibody Drugs Price by Type

4.3.1 Global Antibody Drugs Price by Type (2019-2024)

4.3.2 Global Antibody Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Antibody Drugs Sales by Application

5.1.1 Global Antibody Drugs Historical Sales by Application (2019-2024)

5.1.2 Global Antibody Drugs Forecasted Sales by Application (2025-2030)

5.1.3 Global Antibody Drugs Sales Market Share by Application (2019-2030)

5.2 Global Antibody Drugs Revenue by Application

5.2.1 Global Antibody Drugs Historical Revenue by Application (2019-2024)

5.2.2 Global Antibody Drugs Forecasted Revenue by Application (2025-2030)

5.2.3 Global Antibody Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Antibody Drugs Price by Application

5.3.1 Global Antibody Drugs Price by Application (2019-2024)

5.3.2 Global Antibody Drugs Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Antibody Drugs Market Size by Type

6.1.1 US & Canada Antibody Drugs Sales by Type (2019-2030)

6.1.2 US & Canada Antibody Drugs Revenue by Type (2019-2030)

6.2 US & Canada Antibody Drugs Market Size by Application

6.2.1 US & Canada Antibody Drugs Sales by Application (2019-2030)

6.2.2 US & Canada Antibody Drugs Revenue by Application (2019-2030)

6.3 US & Canada Antibody Drugs Market Size by Country

6.3.1 US & Canada Antibody Drugs Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Antibody Drugs Sales by Country (2019-2030)

6.3.3 US & Canada Antibody Drugs Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Antibody Drugs Market Size by Type

7.1.1 Europe Antibody Drugs Sales by Type (2019-2030)

7.1.2 Europe Antibody Drugs Revenue by Type (2019-2030)

7.2 Europe Antibody Drugs Market Size by Application

7.2.1 Europe Antibody Drugs Sales by Application (2019-2030)

7.2.2 Europe Antibody Drugs Revenue by Application (2019-2030)

7.3 Europe Antibody Drugs Market Size by Country

7.3.1 Europe Antibody Drugs Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Antibody Drugs Sales by Country (2019-2030)

7.3.3 Europe Antibody Drugs Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Antibody Drugs Market Size

8.1.1 China Antibody Drugs Sales (2019-2030)

8.1.2 China Antibody Drugs Revenue (2019-2030)

8.2 China Antibody Drugs Market Size by Application

8.2.1 China Antibody Drugs Sales by Application (2019-2030)

8.2.2 China Antibody Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Antibody Drugs Market Size by Type

9.1.1 Asia Antibody Drugs Sales by Type (2019-2030)

9.1.2 Asia Antibody Drugs Revenue by Type (2019-2030)

9.2 Asia Antibody Drugs Market Size by Application

9.2.1 Asia Antibody Drugs Sales by Application (2019-2030)

9.2.2 Asia Antibody Drugs Revenue by Application (2019-2030)

9.3 Asia Antibody Drugs Sales by Region

9.3.1 Asia Antibody Drugs Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Antibody Drugs Revenue by Region (2019-2030)

9.3.3 Asia Antibody Drugs Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Antibody Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Antibody Drugs Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Antibody Drugs Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Antibody Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Antibody Drugs Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Antibody Drugs Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Antibody Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Antibody Drugs Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Antibody Drugs Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Antibody Drugs Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Novartis

11.1.1 Novartis Company Information

11.1.2 Novartis Overview

11.1.3 Novartis Antibody Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Novartis Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Novartis Recent Developments

11.2 Amgen

11.2.1 Amgen Company Information

11.2.2 Amgen Overview

11.2.3 Amgen Antibody Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Amgen Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Amgen Recent Developments

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Information

11.3.2 Bristol-Myers Squibb Overview

11.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Bristol-Myers Squibb Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Bristol-Myers Squibb Recent Developments

11.4 F. Hoffmann-La Roche

11.4.1 F. Hoffmann-La Roche Company Information

11.4.2 F. Hoffmann-La Roche Overview

11.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 F. Hoffmann-La Roche Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 F. Hoffmann-La Roche Recent Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Information

11.5.2 Johnson & Johnson Overview

11.5.3 Johnson & Johnson Antibody Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Johnson & Johnson Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Johnson & Johnson Recent Developments

11.6 AbbVie

11.6.1 AbbVie Company Information

11.6.2 AbbVie Overview

11.6.3 AbbVie Antibody Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 AbbVie Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 AbbVie Recent Developments

11.7 Eli Lilly

11.7.1 Eli Lilly Company Information

11.7.2 Eli Lilly Overview

11.7.3 Eli Lilly Antibody Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Eli Lilly Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Eli Lilly Recent Developments

11.8 Pfizer

11.8.1 Pfizer Company Information

11.8.2 Pfizer Overview

11.8.3 Pfizer Antibody Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Pfizer Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Pfizer Recent Developments

11.9 Bayer

11.9.1 Bayer Company Information

11.9.2 Bayer Overview

11.9.3 Bayer Antibody Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Bayer Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Bayer Recent Developments

11.10 GlaxoSmithKline

11.10.1 GlaxoSmithKline Company Information

11.10.2 GlaxoSmithKline Overview

11.10.3 GlaxoSmithKline Antibody Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 GlaxoSmithKline Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 GlaxoSmithKline Recent Developments

11.11 Sanofi

11.11.1 Sanofi Company Information

11.11.2 Sanofi Overview

11.11.3 Sanofi Antibody Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Sanofi Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Sanofi Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Antibody Drugs Industry Chain Analysis

12.2 Antibody Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Antibody Drugs Production Mode & Process

12.4 Antibody Drugs Sales and Marketing

12.4.1 Antibody Drugs Sales Channels

12.4.2 Antibody Drugs Distributors

12.5 Antibody Drugs Customers

13 Market Dynamics

13.1 Antibody Drugs Industry Trends

13.2 Antibody Drugs Market Drivers

13.3 Antibody Drugs Market Challenges

13.4 Antibody Drugs Market Restraints

14 Key Findings in The Global Antibody Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Antibody Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Monoclonal Antibodies

Table 3. Major Manufacturers of Antibody-Drug Conjugates

Table 4. Major Manufacturers of Polyclonal Antibodies

Table 5. Global Antibody Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Antibody Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Antibody Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Antibody Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Antibody Drugs Revenue Market Share by Region (2019-2024)

Table 10. Global Antibody Drugs Revenue Market Share by Region (2025-2030)

Table 11. Global Antibody Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Antibody Drugs Sales by Region (2019-2024) & (g)

Table 13. Global Antibody Drugs Sales by Region (2025-2030) & (g)

Table 14. Global Antibody Drugs Sales Market Share by Region (2019-2024)

Table 15. Global Antibody Drugs Sales Market Share by Region (2025-2030)

Table 16. Global Antibody Drugs Sales by Manufacturers (2019-2024) & (g)

Table 17. Global Antibody Drugs Sales Share by Manufacturers (2019-2024)

Table 18. Global Antibody Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Antibody Drugs Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Antibody Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. Antibody Drugs Price by Manufacturers 2019-2024 (USD/mg)

Table 22. Global Antibody Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Antibody Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drugs as of 2023)

Table 24. Global Key Manufacturers of Antibody Drugs, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Antibody Drugs, Product Offered and Application

Table 26. Global Key Manufacturers of Antibody Drugs, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Antibody Drugs Sales by Type (2019-2024) & (g)

Table 29. Global Antibody Drugs Sales by Type (2025-2030) & (g)

Table 30. Global Antibody Drugs Sales Share by Type (2019-2024)

Table 31. Global Antibody Drugs Sales Share by Type (2025-2030)

Table 32. Global Antibody Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Antibody Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Antibody Drugs Revenue Share by Type (2019-2024)

Table 35. Global Antibody Drugs Revenue Share by Type (2025-2030)

Table 36. Antibody Drugs Price by Type (2019-2024) & (USD/mg)

Table 37. Global Antibody Drugs Price Forecast by Type (2025-2030) & (USD/mg)

Table 38. Global Antibody Drugs Sales by Application (2019-2024) & (g)

Table 39. Global Antibody Drugs Sales by Application (2025-2030) & (g)

Table 40. Global Antibody Drugs Sales Share by Application (2019-2024)

Table 41. Global Antibody Drugs Sales Share by Application (2025-2030)

Table 42. Global Antibody Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Antibody Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Antibody Drugs Revenue Share by Application (2019-2024)

Table 45. Global Antibody Drugs Revenue Share by Application (2025-2030)

Table 46. Antibody Drugs Price by Application (2019-2024) & (USD/mg)

Table 47. Global Antibody Drugs Price Forecast by Application (2025-2030) & (USD/mg)

Table 48. US & Canada Antibody Drugs Sales by Type (2019-2024) & (g)

Table 49. US & Canada Antibody Drugs Sales by Type (2025-2030) & (g)

Table 50. US & Canada Antibody Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Antibody Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Antibody Drugs Sales by Application (2019-2024) & (g)

Table 53. US & Canada Antibody Drugs Sales by Application (2025-2030) & (g)

Table 54. US & Canada Antibody Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Antibody Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Antibody Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Antibody Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Antibody Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Antibody Drugs Sales by Country (2019-2024) & (g)

Table 60. US & Canada Antibody Drugs Sales by Country (2025-2030) & (g)

Table 61. Europe Antibody Drugs Sales by Type (2019-2024) & (g)

Table 62. Europe Antibody Drugs Sales by Type (2025-2030) & (g)

Table 63. Europe Antibody Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Antibody Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Antibody Drugs Sales by Application (2019-2024) & (g)

Table 66. Europe Antibody Drugs Sales by Application (2025-2030) & (g)

Table 67. Europe Antibody Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Antibody Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Antibody Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Antibody Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Antibody Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Antibody Drugs Sales by Country (2019-2024) & (g)

Table 73. Europe Antibody Drugs Sales by Country (2025-2030) & (g)

Table 74. China Antibody Drugs Sales by Type (2019-2024) & (g)

Table 75. China Antibody Drugs Sales by Type (2025-2030) & (g)

Table 76. China Antibody Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Antibody Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Antibody Drugs Sales by Application (2019-2024) & (g)

Table 79. China Antibody Drugs Sales by Application (2025-2030) & (g)

Table 80. China Antibody Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Antibody Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Antibody Drugs Sales by Type (2019-2024) & (g)

Table 83. Asia Antibody Drugs Sales by Type (2025-2030) & (g)

Table 84. Asia Antibody Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Antibody Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Antibody Drugs Sales by Application (2019-2024) & (g)

Table 87. Asia Antibody Drugs Sales by Application (2025-2030) & (g)

Table 88. Asia Antibody Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Antibody Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Antibody Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Antibody Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Antibody Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Antibody Drugs Sales by Region (2019-2024) & (g)

Table 94. Asia Antibody Drugs Sales by Region (2025-2030) & (g)

Table 95. Middle East, Africa and Latin America Antibody Drugs Sales by Type (2019-2024) & (g)

Table 96. Middle East, Africa and Latin America Antibody Drugs Sales by Type (2025-2030) & (g)

Table 97. Middle East, Africa and Latin America Antibody Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Antibody Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Antibody Drugs Sales by Application (2019-2024) & (g)

Table 100. Middle East, Africa and Latin America Antibody Drugs Sales by Application (2025-2030) & (g)

Table 101. Middle East, Africa and Latin America Antibody Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Antibody Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Antibody Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Antibody Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Antibody Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Antibody Drugs Sales by Country (2019-2024) & (g)

Table 107. Middle East, Africa and Latin America Antibody Drugs Sales by Country (2025-2030) & (g)

Table 108. Novartis Company Information

Table 109. Novartis Description and Major Businesses

Table 110. Novartis Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 111. Novartis Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Novartis Recent Developments

Table 113. Amgen Company Information

Table 114. Amgen Description and Major Businesses

Table 115. Amgen Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 116. Amgen Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Amgen Recent Developments

Table 118. Bristol-Myers Squibb Company Information

Table 119. Bristol-Myers Squibb Description and Major Businesses

Table 120. Bristol-Myers Squibb Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 121. Bristol-Myers Squibb Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Bristol-Myers Squibb Recent Developments

Table 123. F. Hoffmann-La Roche Company Information

Table 124. F. Hoffmann-La Roche Description and Major Businesses

Table 125. F. Hoffmann-La Roche Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 126. F. Hoffmann-La Roche Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. F. Hoffmann-La Roche Recent Developments

Table 128. Johnson & Johnson Company Information

Table 129. Johnson & Johnson Description and Major Businesses

Table 130. Johnson & Johnson Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 131. Johnson & Johnson Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Johnson & Johnson Recent Developments

Table 133. AbbVie Company Information

Table 134. AbbVie Description and Major Businesses

Table 135. AbbVie Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 136. AbbVie Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. AbbVie Recent Developments

Table 138. Eli Lilly Company Information

Table 139. Eli Lilly Description and Major Businesses

Table 140. Eli Lilly Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 141. Eli Lilly Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Eli Lilly Recent Developments

Table 143. Pfizer Company Information

Table 144. Pfizer Description and Major Businesses

Table 145. Pfizer Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 146. Pfizer Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. Pfizer Recent Developments

Table 148. Bayer Company Information

Table 149. Bayer Description and Major Businesses

Table 150. Bayer Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 151. Bayer Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Bayer Recent Developments

Table 153. GlaxoSmithKline Company Information

Table 154. GlaxoSmithKline Description and Major Businesses

Table 155. GlaxoSmithKline Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 156. GlaxoSmithKline Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. GlaxoSmithKline Recent Developments

Table 158. Sanofi Company Information

Table 159. Sanofi Description and Major Businesses

Table 160. Sanofi Antibody Drugs Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 161. Sanofi Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. Sanofi Recent Developments

Table 163. Key Raw Materials Lists

Table 164. Raw Materials Key Suppliers Lists

Table 165. Antibody Drugs Distributors List

Table 166. Antibody Drugs Customers List

Table 167. Antibody Drugs Market Trends

Table 168. Antibody Drugs Market Drivers

Table 169. Antibody Drugs Market Challenges

Table 170. Antibody Drugs Market Restraints

Table 171. Research Programs/Design for This Report

Table 172. Key Data Information from Secondary Sources

Table 173. Key Data Information from Primary Sources

List of Figures

Figure 1. Antibody Drugs Product Picture

Figure 2. Global Antibody Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Antibody Drugs Market Share by Type in 2023 & 2030

Figure 4. Monoclonal Antibodies Product Picture

Figure 5. Antibody-Drug Conjugates Product Picture

Figure 6. Polyclonal Antibodies Product Picture

Figure 7. Global Antibody Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Antibody Drugs Market Share by Application in 2023 & 2030

Figure 9. Central Nervous System (CNS) Disorders

Figure 10. Cancers

Figure 11. Autoimmune Disorders

Figure 12. Cardiovascular Diseases

Figure 13. Antibody Drugs Report Years Considered

Figure 14. Global Antibody Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Antibody Drugs Revenue 2019-2030 (US$ Million)

Figure 16. Global Antibody Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 17. Global Antibody Drugs Revenue Market Share by Region (2019-2030)

Figure 18. Global Antibody Drugs Sales 2019-2030 ((g)

Figure 19. Global Antibody Drugs Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Antibody Drugs Sales YoY (2019-2030) & (g)

Figure 21. US & Canada Antibody Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Antibody Drugs Sales YoY (2019-2030) & (g)

Figure 23. Europe Antibody Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Antibody Drugs Sales YoY (2019-2030) & (g)

Figure 25. China Antibody Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Antibody Drugs Sales YoY (2019-2030) & (g)

Figure 27. Asia (excluding China) Antibody Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Antibody Drugs Sales YoY (2019-2030) & (g)

Figure 29. Middle East, Africa and Latin America Antibody Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 30. The Antibody Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 31. The Top 5 and 10 Largest Manufacturers of Antibody Drugs in the World: Market Share by Antibody Drugs Revenue in 2023

Figure 32. Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 33. Global Antibody Drugs Sales Market Share by Type (2019-2030)

Figure 34. Global Antibody Drugs Revenue Market Share by Type (2019-2030)

Figure 35. Global Antibody Drugs Sales Market Share by Application (2019-2030)

Figure 36. Global Antibody Drugs Revenue Market Share by Application (2019-2030)

Figure 37. US & Canada Antibody Drugs Sales Market Share by Type (2019-2030)

Figure 38. US & Canada Antibody Drugs Revenue Market Share by Type (2019-2030)

Figure 39. US & Canada Antibody Drugs Sales Market Share by Application (2019-2030)

Figure 40. US & Canada Antibody Drugs Revenue Market Share by Application (2019-2030)

Figure 41. US & Canada Antibody Drugs Revenue Share by Country (2019-2030)

Figure 42. US & Canada Antibody Drugs Sales Share by Country (2019-2030)

Figure 43. U.S. Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 44. Canada Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 45. Europe Antibody Drugs Sales Market Share by Type (2019-2030)

Figure 46. Europe Antibody Drugs Revenue Market Share by Type (2019-2030)

Figure 47. Europe Antibody Drugs Sales Market Share by Application (2019-2030)

Figure 48. Europe Antibody Drugs Revenue Market Share by Application (2019-2030)

Figure 49. Europe Antibody Drugs Revenue Share by Country (2019-2030)

Figure 50. Europe Antibody Drugs Sales Share by Country (2019-2030)

Figure 51. Germany Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 52. France Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 53. U.K. Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 54. Italy Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 55. Russia Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 56. China Antibody Drugs Sales Market Share by Type (2019-2030)

Figure 57. China Antibody Drugs Revenue Market Share by Type (2019-2030)

Figure 58. China Antibody Drugs Sales Market Share by Application (2019-2030)

Figure 59. China Antibody Drugs Revenue Market Share by Application (2019-2030)

Figure 60. Asia Antibody Drugs Sales Market Share by Type (2019-2030)

Figure 61. Asia Antibody Drugs Revenue Market Share by Type (2019-2030)

Figure 62. Asia Antibody Drugs Sales Market Share by Application (2019-2030)

Figure 63. Asia Antibody Drugs Revenue Market Share by Application (2019-2030)

Figure 64. Asia Antibody Drugs Revenue Share by Region (2019-2030)

Figure 65. Asia Antibody Drugs Sales Share by Region (2019-2030)

Figure 66. Japan Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 67. South Korea Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 68. China Taiwan Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 69. Southeast Asia Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 70. India Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 71. Middle East, Africa and Latin America Antibody Drugs Sales Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Antibody Drugs Revenue Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Antibody Drugs Sales Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Antibody Drugs Revenue Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Antibody Drugs Revenue Share by Country (2019-2030)

Figure 76. Middle East, Africa and Latin America Antibody Drugs Sales Share by Country (2019-2030)

Figure 77. Brazil Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 78. Mexico Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 79. Turkey Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 80. Israel Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 81. GCC Countries Antibody Drugs Revenue (2019-2030) & (US$ Million)

Figure 82. Antibody Drugs Value Chain

Figure 83. Antibody Drugs Production Process

Figure 84. Channels of Distribution

Figure 85. Distributors Profiles

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-17Q10023

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pre-Clinical Chemistry Testing Device for Laboratory Animal Models Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-8U10163

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Fast-disintegrating Tablets Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-11I9951

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Immuno Oncology Assays Kit Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-34H832

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Antibody Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-39V1652

Global Antibody Drugs Market Insights, Forecast to 2030

FEATURED COMPANIES

Antibody Drugs Market Size

Antibody Drugs Market

Scope of Antibody Drugs Market Report

Chapter Outline

FAQ for this report

How fast is Antibody Drugs Market growing?

What is the Antibody Drugs Market size in 2030?

Who are the main players in the Antibody Drugs Market report?

What are the Application segmentation covered in the Antibody Drugs Market report?

What are the Type segmentation covered in the Antibody Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS